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Abstract Phospholipase A2 activation by membrane-bound pep- 
tides was investigated in order to understand the role of the 
membrane-induced conformation on activation, and to examine 
the occurrence of a peptide-enzyme complex at the fipid/water 
interface. For the peptides studied, bee venom phospholipase A2 
was stimulated regardless of the membrane-bound conformation 
(a-helix, i~-sheet or random coil). Using antisera raised against 
mefittin, we were able to demonstrate the occurrence of a cal- 
cium-dependent complex involving the enzyme, phospholipid sub- 
strate, and peptide. 
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I. Introduction 
Phospholipases A2 (PLA2) (EC 3.1.1.4) are a family of 
lipolytic enzymes that specifically catalyze the hydrolysis of the 
2-acyl ester bond in 3-sn-phosphoglycerides in the presence of 
Ca 2+ [1]. These enzymes are encountered both inside and out- 
side the cell. The extracellular enzymes are relatively small 
proteins (ca. 14 kDa) containing multiple disulfide bridges, and 
are found in high concentrations in mammalian pancreatic juice 
as well as in snake and bee venoms. The water-soluble forms 
of these extracellular enzymes are the most thoroughly studied 
and have been used as model systems for the less tractable, 
membrane-bound forms, as well as for the study of enzyme 
catalysis at lipid/water interfaces [2]. The lipid homogeneity as 
well as the presence of charged groups at lipid/water interfaces 
were found to affect the PLA2 enzymatic activity [3]. Such 
interracial charges can be provided by detergents, ionized fatty 
acids, head-groups of phospholipids or, interestingly, by mem- 
brane-bound peptides [4,5]. Special interest in the mechanism 
of PLA2 action stems from its role as a model system for the 
study of calcium-mediated nzymatic events at the surface of 
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Abbreviations: CD, circular dichroism; EPC, egg yolk phosphati- 
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dylserine; RBC, red blood cell; RP-HPLC, reversed phase-high per- 
formance liquid chromatography; SUV, small unilamellar vesicle. 
membranes, especially those that release arachidonate and 
other second messengers. 
Melittin, an amphipathic 26-amino acid peptide that is one 
of the main constituents ofhoney bee venom, has been reported 
to enhance the activity of venom PLA2 [6-10], as well as to 
show modest calcium-dependent phospholipase-like activity 
[11]. The observed synergistic effect of melittin with PLA2 was 
proposed in earlier studies to be caused by structural perturba- 
tions of the lipid bilayer induced by melittin. This was found 
to correlate with a reorientation of the phospholipid 2-acyl 
ester bond. Although the function of melittin is known to be 
involved in bee venom's lytic activity, melittin has also been 
shown to stimulate phospholipase activity in rat tissue homoge- 
nares and to cause a dose-dependent release of arachidonic acid 
from rat peritoneal mast cells and cultured human fibroblasts 
[8]. Moreover, the possibility that mammalian cells also contain 
small peptides which facilitate phospholipase activity has not 
been excluded. 
The present investigation was carried out to further deter- 
mine whether the presence of small peptides, which have high 
binding affinity to artificial and biological membranes, influ- 
ence the regulatory mechanism of PLA2 activation. The role 
of the induced conformation upon binding to lipids was also 
studied using melittin and eight synthetic peptides that cover 
different structural arrangements for the membrane-bound 
peptide state. Moreover, the occurrence of a PLA2-peptide 
complex was demonstrated using melittin antisera. 
2. Materials and methods 
2.1. Peptide synthesis 
Peptides were prepared by simultaneous multiple peptide synthesis 
using t-butoxycarbonyl chemistry as described elsewhere [12]. Final 
cleavage and deprotection were carried out using a 'low-high' hydrogen 
fluoride procedure and a 24-vessel cleavage apparatus [13,14]. The 
peptides were purified by preparative r versed phase-high performance 
liquid chromatography (RP-HPLC) using a DeltaPrep 3000 system 
combined with a Foxy fraction collector (Millipore, Waters Division, 
San Francisco, CA, USA). Analytical RP-HPLC and matrix-assisted 
laser desorption time-of-flight mass spectroscopy (Kompact Maldi-Tof 
mass spectrometer - -  Kratos, Ramsey, N J, USA) were used to deter- 
mine the final purity and identity of the peptides. 
2.2. Preparation of phospholipid liposomes 
A mixture of egg yolk phosphatidylcholine (EPC) and bovine brain 
phosphatidylserine (PS; Sigma, St. Louis, MO, USA) at a molar atio 
of 92:8 was dissolved in a chloroform/methanol (9:1 (v/v)) mixture and 
dried by a stream of nitrogen gas. The dried lipid was hydrated in 10 
mM Tris-HC1 buffer, pH 8.0, to a 6.25 mM final concentration, with 
repeat vortex mixing for 15 rain. To generate small unilamellar vesicles 
(SUVs), the cloudy suspension was sonicated in an ice-water bath for 
20 rain using an ultrasonic generator equipped with a microtip robe 
(Vibra cell, Sonics and Materials, Danbury, CT, USA). 
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2.3. PLA2 assay 
It should be noted that the use of synthetic peptides in the present 
study eliminates the possibility of venom PLA2 contamination as found 
in the commonly used natural melittins. The PLA2 reaction mixture 
contained 10 mM Tris-HC1 buffer, pH 8.0, 1.2 mM CaC12, 2.85 mM 
SUVs, 0.5 Hg enzyme, and varying peptide concentrations (5-90 ftM). 
The reaction was run at 25°C for 10 rain. 20/11 aliquots of the reaction 
mixture were withdrawn and boiled to stopped the reaction. The simul- 
taneous disappearance of phospholipid and appearance of its lyso de- 
rivative were monitored by normal phase HPLC as described elsewhere 
[15] using a Waters Resolve column (90 A normal pore size). 
2.4. Circular dichroism measurements 
All measurements were carried out on a Jasco J720 circular di- 
chroism spectropolarimeter (CD; Eaton, MD, USA) in conjunction 
with a Neslab RTE 110 waterbath and temperature controller (Dublin, 
CA, USA). CD spectra were the average of a series of 3-7 scans made 
at 0.2 nm intervals. CD spectra of buffer containing SUVs without 
peptide were used as a baseline in all of the experiments. Ellipticity is 
reported as the mean molar residue llipticity [0]; the limits of error of 
measurements at 222 nm were _+ 500deg. cm 2- dmol-L Peptide concen- 
trations were determined by UV spectrophotometry in buffer and in the 
presence of 7.2 M guanidine-HCl, at 280 nm in the case of melittin and 
melittin-related peptides using the reported extinction coefficient for 
melittin in buffer (e280 = 5570 M -1 .cm -1 [16], at 276 nm in the case of 
tyrosine-containing peptides using ~276 = 1450 M -~'cm -~ [17] or by 
quantitative amino acid analyses (Multiple Peptide Systems, San Diego, 
CA, USA) for peptides without aromatic residues. 
2.5. Hemolytic assay 
The hemolytic activities of the peptides were determined using 
human red blood cells (RBCs). The blood was collected in heparin, 
maintained at 4°C, and used either the same day or the following day. 
The cells were washed three times with phosphate-buffered saline (PBS/ 
35 mM phosphate buffer- 0.15 M NaC1, pH 7.0) and resuspended in 
PBS. The hemolytic activity of the peptides were determined as de- 
scribed [18] using 96-well tissue culture plates. In brief, 100HI of a 0.5% 
RBC suspension was added to an equal volume of each peptide in PBS. 
The plates were incubated for 1 h at 37°C and the optical density (OD) 
of the supernatant was measured at 414 nm. The concentration of
peptide necessary to lyse 50% RBCs (HDs0) was then determined for 
each peptide using a sigmoidal curve-fitting method (Graphpad, ISL 
San Diego, CA, USA). 
2.6. Melittin ant&era and ELISA 
New Zealand white rabbits were first injected with melittin (500/lg) 
in 1 ml PBS/complete Freund's adjuvant emulsion. Boosts were per- 
formed approximately every 30th day with melittin emulsified in incom- 
plete Freund's adjuvant. Blood was collected 14 days after the fifth 
injection. Antisera were titered against melittin by direct ELISA. 
The direct ELISA used here is similar to the method previously 
described [19]. Briefly, melittin (10/tg/ml), PLA2, SUVs, lysophosphat- 
idylcholine (LPC), as well as all combinations thereof, were adsorbed 
to 96-well polystyrene microtiter plates (A/2, Costar, Cambridge, MA, 
USA) in Tris buffer, pH 8.0, at the same relative concentrations u ed 
in the PLA2 assay mentioned above. Plates were incubated for 2 h at 
37°C, washed with distilled water, and blocked with 1.5% BSA in PBS 
for nonspecific binding. Antisera were serially diluted two-fold and 
incubated for 1 h at 37°C. Goat anti-rabbit antibody-horseradish per- 
oxidase conjugate (1 : 1000, Calbiochem, San Diego, CA, USA) was 
added to detect bound antisera. Plates were developed with OPD/H202 
(Sigma) for 10 min before stopping the reaction with sulfuric acid. 
Optical densities were measured at 492 nm on a Titertek Multiscan 
plate reader. 
3. Results 
3.1. Activation o f  bee venom PLA2 by melittin and melittin 
substitution analogues 
The factors involved in the reported synergistic effect of 
melittin on PLA2 activity were investigated using two ana- 
logues of melittin, resulting from substitution of lysine-7 by 
either a nonpolar  amino acid (Ile, analog subK7I), or by a 
negatively charged amino acid (Glu, analog subK7E). Lysine-7 
is the only positively charged amino acid not located at the 
C-terminus of the natural  melittin, and was found earlier to be 
critical for both melittin's folding ability and biological activity 
[20]. Melittin and its two analogues were found to bind to 
artificial membranes with similar affinity [20], which was antic- 
ipated due to their identical charged C-terminal regions. Thus, 
we believe that the initial driving force for the interaction of 
melittin with phosphol ipid membranes involves electrostatic 
interactions between the highly positively charged C-terminus 
of melittin and the phosphol ipid head groups [21]. Conforma- 
tional studies using CD spectroscopy showed that, upon in- 
creasing the ratio [SUVs]/[peptide] (R~p), a gradual conforma- 
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Fig. 1. Activation of bee venom phospholipase A 2 hydrolysis of SUVs 
by melittin (A), subK7E (B), and subK7I (C). The reaction was per- 
formed and monitored as described in section 2. Each point is the 
mean + S.E.M. of three experiments made in duplicate. 
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Fig. 2. CD spectra of representative peptides in the presence ofSUVs. 
The CD spectra were recorded at a peptide concentration f 50 JIM in 
5 mM MOPS buffer in the presence ofEPC/PS SUVs at a ratio R~p = 50. 
The mean residue llipticities ([0] in deg. cm 2.dmoV ~) are shown for 
melittin (solid line), YLK (dotted line), KL (dashed line), GKP (crossed 
line), and GEP (centered line). 
tional change occurred in which a random conformation con- 
verted to an ~-helix for melittin and subK7E. In contrast, dif- 
ferent degrees offl-structure were observed for subK7I at a low 
SUV content, while subK7I was predominantly c~-helical t Rip 
values higher than 30 [20]. These differences in folding ability 
were found to correlate with variations in hemolytic and anti- 
microbial activities [20]. 
Melittin, subK7E, and subK7I stimulated bee venom PLA2 
equally (on a molar basis) in a dose-dependent manner, reach- 
ing a plateau at a common 40¢tM peptide concentration (Fig. 
1). At this concentration, anincrease in PLA2 activity of up to 
approximately 500% of control values (i.e. without peptide 
added) was observed in the presence of any of the three pep- 
tides. It should be noted that under these experimental condi- 
tions (peptide concentration upto 80 pM and R~p values higher 
or equal to 35), the three peptides all adopt an c~-helical confor- 
mation. This suggests that the presence of a positive charge at 
position 7 has no specific role in the peptide-induced nhance- 
ment of PLA2 activity. 
3.2. Activation of bee venom PLA2 by peptides having different 
structural motiJg" 
In order to study the importance ofpeptide conformation on 
the activation of PLA2, peptides were designed to adopt differ- 
ent structural motifs (c~-helix, fl-sheet and random coil - Table 
l) upon binding to SUVs (phospholipid substrate used on the 
PLA2 activity experiments). The ellipticity values at 222 nm as 
determined by CD spectroscopy (Fig. 2) in the presence of 
saturating concentrations of SUVs, as well as the induced struc- 
tural motifs for all the peptides tested, are described in Table 
1. When assayed for PLA2 activation, only GEl?, and the two 
truncation analogues of melittin had little effect on PLA2 activ- 
ity. These results indicate that the enhancement of the catalytic 
activity of PLA2 is independent of the structural motif adopted 
by the peptide upon binding to the membrane. The weak effect 
seen for GEP may be explained by the fact that GEP, in con- 
trast to the other peptides, does not bind to the SUVs. This is 
due to electrostatic repulsions between the negatively charged 
side chain of glutamic acid residues and the negative charge 
density of the SUVs. Although melittin's truncation analogues 
were found to have strong binding affinity to SUVs, resulting 
in the adoption of an c~-helical conformation (Table 1), their 
weak PLA2 activation activity may be due to their short length 
as compared to the other peptides tudied. Interestingly, no 
correlation was found between the hemolytic activity of these 
peptides and their ability to activate the enzyme (Table 1). 
Thus, peptides having very weak hemolytic activity, such as 
subK7I, KL and GKP, were found to enhance PLA2 activity 
to the same extent as the highly hemolytic peptides melittin, 
subK7E, and YLK. These results indicate that membrane dis- 
ruption does not appear to be a necessary criterion for activa- 
tion of PLA2. In contrast, perturbation of the membrane ho- 
mogeneity resulting from the peptide binding to SUVs was 
found in this study to facilitate the activity of PLA2. Finally, 
it is noteworthy that none of the peptides were able to replace 
Ca 2+ as a PLA2 effector, since no PLA2 activity could be 
detected in the presence of EDTA. 
Table 1 
Lipid-induced structural motifs in the presence of SUVs" and biological activities of the peptides studied 
Name Peptide sequence Motif [0]222 PLA2 Activity HDs0 
(deg'cm 2.dmOl-') (% of control l (/.tg/ml) 
melittin GIGAVLKVLTTGLPAL ISWIKRKRQQ-NH 2 c~ -27630 470 +_ 50 2.55 
subK7E G IGAVLW.VLTTGLPAL ISWIKRKRQQ-NH2 ~ -31700 490 + 30 4.00 
subK71 G IGAVLXVLTTGLPAL ISWIKRKRQQ-NH 2 o~ -29460 460 + 40 > 500 
mel( I - 13) GIGAVLKVLTTGL-NH 2 C~ -30710 270 + 60 > 500 
mei(14-26) Ac -PAL ISWIKRKRQQ-NH 2 C~ -26690 230 + 30 >500 
YLK  YKLLKKLLKKLKKLLKKL-NH 2 c~ -23700 420 + 40 4.08 
KL  KLKLKLKLKLKLKLKLKL-NH 2 fl - 14890 430 +_ 30 > 500 
GKP KGKPGKPGKPGKPGKPGKPK-NH 2 random - 2400 400 + 30 >500 
GEP KGEPGEPGEPGEPGEPGEPK-NH 2 random - 3040 120 + 20 > 500 
The CD spectra were recorded at a peptide concentration f 50 ¢tM and Rtp= 50. 
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Fig. 3. Immunological evidence for melittin-PLA2 complexation. Me- 
littin recognition by different dilutions of melittin antisera was deter- 
mined under the same xperimental conditions used in PLA2 activation 
experiments. The OD readings at 492 nm are plotted for melittin in the 
presence of SUVs (n), PLA2 (z~), both SUVs and PLA2 (v), and SUVs, 
PLA2 and EDTA (<>). 
3.3. Immunological evidence of the formation of a peptide-PLA2 
complex 
To investigate the possible occurrence of a peptide-PLA2 
complex in the presence of phospholipid membranes, immuno- 
logical studies were carried out using melittin as a representa- 
tive peptide model. Thus, melittin antisera were used to detect 
free melittin by ELISA. Fig. 3 shows the recognition ofmelittin 
at different dilutions of antisera under the same experimental 
conditions used in the PLA2 activation experiments. Excellent 
recognition was found for melittin in the presence of the sub- 
strate of the enzymatic reaction (SUVs) or in the presence of 
PLA2 (Fig. 3). However, a small decrease in recognition was 
observed in the presence of the hydrolysis product (LPC), with 
or without PLA2 (data not shown). In contrast, no significant 
recognition was found when PLA2 was added to melittin in the 
presence of SUVs under the initial conditions used for the 
PLA2 activation experiments, even at the highest antiserum 
concentration (dilution 1/2000 - Fig. 3). These results indicate 
that the formation of a complex between melittin and PLA2 
occurs only in the presence of SUVs. Interestingly, when PLA2 
was inactivated with EDTA, melittin was strongly recognized 
in the presence of SUVs and enzyme (Fig. 3). This later result 
supports the hypothesis that Ca2+-activated PLA2 interacts 
with melittin. Using truncation analogues of melittin, the anti- 
sera were found to recognize the last four residues at the C- 
terminal region of melittin (data not shown). The loss of recog- 
nition observed for melittin may be explained by interactions 
between PLA2 and the C-terminal region of melittin. 
4. Discussion and conclusion 
The present studies resulted in several clarifying observations 
concerning the role of membrane-bound peptides in PLA2 ac- 
tivation. Despite the differences in their primary structure, or 
membrane-induced secondary structure, the peptides melittin, 
subK7E, subK7I, YLK, KL, and GKP were found to equally 
activate bee venom PLA2 only when the enzyme was activated 
with Ca 2+. Membrane-active p ptides uch as melittin and mas- 
toparan have been reported to facilitate phospholipase activity 
[6-10], which is known to be enhanced by alterations in lipid 
substrate packing caused by the presence of such peptides. 
However, the present studies show that nonlytic membrane- 
bound peptides may also enhance phospholipase activity re- 
gardless of their membrane-induced conformation. As was 
shown by the weak PLA2 activation observed for reel(i-13) 
and me1(14-26), the binding ability of peptides to SUVs, while 
essential, does not appear to be sufficient in itself or activation 
to occur. 
Self-complexation f PLA2 from different sources has been 
reported to dramatically increase its catalytic activity [22]. In 
the present study, we have shown that peptide-induced activa- 
tion of PLA2 correlates with the formation of a complex that 
involves not only the enzyme and peptide, but also the phos- 
pholipid substrate and calcium. Although the nature of this 
complex must be investigated further, one can envision that 
such peptide-enzyme complexes have properties imilar to 
those resulting from self-complexes of PLA2. 
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